2022 Vol.40, N°2 - Table of contents
February - Myositis 2022
Official organ of the International Myositis Society
(iMyoS - https://imyos.org)
One year in review
CER15392
2022,40,2
Pg. 0199-0209
Free to view
Idiopathic inflammatory myopathies: one year in review 2021
C. Cardelli, G. Zanframundo, L. Cometi, E. Marcucci, A. Biglia, L. Cavagna, S. Barsotti
DOI: https://doi.org/10.55563/clinexprheumatol/vskjxi
C. Cardelli, G. Zanframundo, L. Cometi, E. Marcucci, A. Biglia, L. Cavagna, S. Barsotti
DOI: https://doi.org/10.55563/clinexprheumatol/vskjxi
Editorials
CER15288
2022,40,2
Pg. 0210-0213
Free to view
Introducing the international Myositis Society (iMyoS): a novel multiprofessional society to foster the care, education, and research on myositis
J. Schmidt, P. Korsten, S. Zechel, S. Schlüter
DOI: https://doi.org/10.55563/clinexprheumatol/1a7tkf
J. Schmidt, P. Korsten, S. Zechel, S. Schlüter
DOI: https://doi.org/10.55563/clinexprheumatol/1a7tkf
CER15200
2022,40,2
Pg. 0214-0218
Free to view
The origins, evolution and future of the International Myositis Assessment and Clinical Studies Group (IMACS)
D.A. Isenberg, H. Chinoy, M.M. Dimachkie, F.W. Miller, L.G. Rider
DOI: https://doi.org/10.55563/clinexprheumatol/yg743i
D.A. Isenberg, H. Chinoy, M.M. Dimachkie, F.W. Miller, L.G. Rider
DOI: https://doi.org/10.55563/clinexprheumatol/yg743i
Full Papers
CER13719
2022,40,2
Pg. 0219-0223
Free to view
Anti-Zo antibodies in Japanese myositis patients detected by a newly developed ELISA
Y. Muro, T. Hashimoto, S. Izumi, M. Ogawa-Momohara, T. Takeichi, H. Yamashita, H. Yasuoka, M. Akiyama
DOI: https://doi.org/10.55563/clinexprheumatol/q70vmh
Y. Muro, T. Hashimoto, S. Izumi, M. Ogawa-Momohara, T. Takeichi, H. Yamashita, H. Yasuoka, M. Akiyama
DOI: https://doi.org/10.55563/clinexprheumatol/q70vmh
CER14234
2022,40,2
Pg. 0224-0236
Free to view
A retrospective cohort study in Chinese patients with adult polymyositis and dermatomyositis: risk of comorbidities and subclassification using machine learning
J. Zhu, L. Wu, Y. Zhou, R. Wang, S. Chen, J. Zhao, S. Yu, S. Zheng, F. Xiao, H. Ren, M. Yang, J. Li
DOI: https://doi.org/10.55563/clinexprheumatol/i2xeao
J. Zhu, L. Wu, Y. Zhou, R. Wang, S. Chen, J. Zhao, S. Yu, S. Zheng, F. Xiao, H. Ren, M. Yang, J. Li
DOI: https://doi.org/10.55563/clinexprheumatol/i2xeao
CER14291
2022,40,2
Pg. 0237-0246
Free to view
Dipeptidyl peptidase 4/CD26 expression in human idiopathic inflammatory myopathies reveals skeletal muscle injury and vascular inflammation
R. De Lorenzo, A. Monno, C. Sciorati, I. Lorenzetti, S. Cavalli, F. Bonomi, S.C. Previtali, P. Rovere-Querini
DOI: https://doi.org/10.55563/clinexprheumatol/rdm3kg
R. De Lorenzo, A. Monno, C. Sciorati, I. Lorenzetti, S. Cavalli, F. Bonomi, S.C. Previtali, P. Rovere-Querini
DOI: https://doi.org/10.55563/clinexprheumatol/rdm3kg
CER14226
2022,40,2
Pg. 0247-0253
Free to view
Nomogram to predict dermatomyositis prognosis: a population-based study of 457 cases
Y. Li, Y. Li, Y. Wang, L. Shi, F. Lin, Z. Zhang, J. Zhang, F. Xu, X. Sun
DOI: https://doi.org/10.55563/clinexprheumatol/0ddt88
Y. Li, Y. Li, Y. Wang, L. Shi, F. Lin, Z. Zhang, J. Zhang, F. Xu, X. Sun
DOI: https://doi.org/10.55563/clinexprheumatol/0ddt88
CER14770
2022,40,2
Pg. 0254-0259
Free to view
Infection is not rare in patients with idiopathic inflammatory myopathies
Y.P. Ge, X.M. Shu, L.R. He, G.C. Wang, X. Lu
DOI: https://doi.org/10.55563/clinexprheumatol/yps7ai
Y.P. Ge, X.M. Shu, L.R. He, G.C. Wang, X. Lu
DOI: https://doi.org/10.55563/clinexprheumatol/yps7ai
CER14603
2022,40,2
Pg. 0260-0266
Free to view
Alterations of peripheral blood B cell subsets in Chinese patients with adult idiopathic inflammatory myopathies
Y. Wang, L. Zhu, B. Ju, J. Luo, Q. Li, X. Lv, D. Pu, Z. Hao, J. Wang, L. He
DOI: https://doi.org/10.55563/clinexprheumatol/ohsmuj
Y. Wang, L. Zhu, B. Ju, J. Luo, Q. Li, X. Lv, D. Pu, Z. Hao, J. Wang, L. He
DOI: https://doi.org/10.55563/clinexprheumatol/ohsmuj
CER14868
2022,40,2
Pg. 0267-0273
Free to view
Muscle dysfunction in axial spondylarthritis: the MyoSpA study
A. Neto, R. Pinheiro Torres, S. Ramiro, A. Sardoo, S. Rodrigues-Manica, J. Lagoas-Gomes, L. Domingues, C. Lage Crespo, D. Teixeira, A. Sepriano, A.T. Masi, K. Nair, P. Gomes-Alves, J. Costa, J.C. Branco, F.M. Pimentel-Santos
DOI: https://doi.org/10.55563/clinexprheumatol/9ljng7
A. Neto, R. Pinheiro Torres, S. Ramiro, A. Sardoo, S. Rodrigues-Manica, J. Lagoas-Gomes, L. Domingues, C. Lage Crespo, D. Teixeira, A. Sepriano, A.T. Masi, K. Nair, P. Gomes-Alves, J. Costa, J.C. Branco, F.M. Pimentel-Santos
DOI: https://doi.org/10.55563/clinexprheumatol/9ljng7
CER15088
2022,40,2
Pg. 0274-0283
Free to view
Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies
L. Cavagna, F. Meloni, A. Meyer, G. Sambataro, M. Belliato, E. De Langhe, I. Cavazzana, N. Pipitone, K. Triantafyllias, M. Mosca, S. Barsotti, G. Zampogna, A. Biglia, G. Emmi, M. De Visser, A. Van Der Kooi, P. Parronchi, S. Hirschi, J.A.P. Da Silva, C.A. Scirè, F. Furini, M. Giannini, O. Martinez Gonzalez, L. Damian, Y. Piette, V. Smith, A. Mera-Valera, J. Bachiller-Corral, I. Cabezas Rodriguez, A.M. Brandy-Garcia, F. Maurier, J. Perrin, J. Gonzalez-Moreno, U. Drott, C. Delbruck, A. Schwarting, E. Arrigoni, G.D. Sebastiani, A. Iuliano, C. Nannini, L. Quartuccio, A.B. Rodriguez Cambron, M.Á. Blázquez Cañamero, I. Villa Blanco, G. Cagnotto, A. Pesci, F. Luppi, G. Dei, F.I. Romero Bueno, F. Franceschini, I. Chiapparoli, G. Zanframundo, S. Lettieri, L. De Stefano, M. Cutolo, A. Mathieu, M. Piga, S. Prieto-González, M.F. Moraes-Fontes, J.E. Fonseca, V. Jovani, V. Riccieri, A. Santaniello, S. Montfort, D. Bilocca, G.L. Erre, E. Bartoloni, R. Gerli, M.C. Monti, H.M. Lorenz, D. Sambataro, S. Bellando Randone, U. Schneider, C. Valenzuela, R. Lopez-Mejias, J. Cifrian, M. Mejia, M.-I. Gonzalez Perez, S. Wendel, M. Fornaro, G. De Luca, G. Orsolini, M. Rossini, P. Dieude, J. Knitza, S. Castañeda, R.E. Voll, J. Rojas-Serrano, A. Valentini, C. Vancheri, M. Matucci-Cerinic, E. Feist, V. Codullo, F. Iannone, J.H. Distler, C. Montecucco, M.A. Gonzalez-Gay
on behalf of the AENEAS collaborative group
DOI: https://doi.org/10.55563/clinexprheumatol/di1083
L. Cavagna, F. Meloni, A. Meyer, G. Sambataro, M. Belliato, E. De Langhe, I. Cavazzana, N. Pipitone, K. Triantafyllias, M. Mosca, S. Barsotti, G. Zampogna, A. Biglia, G. Emmi, M. De Visser, A. Van Der Kooi, P. Parronchi, S. Hirschi, J.A.P. Da Silva, C.A. Scirè, F. Furini, M. Giannini, O. Martinez Gonzalez, L. Damian, Y. Piette, V. Smith, A. Mera-Valera, J. Bachiller-Corral, I. Cabezas Rodriguez, A.M. Brandy-Garcia, F. Maurier, J. Perrin, J. Gonzalez-Moreno, U. Drott, C. Delbruck, A. Schwarting, E. Arrigoni, G.D. Sebastiani, A. Iuliano, C. Nannini, L. Quartuccio, A.B. Rodriguez Cambron, M.Á. Blázquez Cañamero, I. Villa Blanco, G. Cagnotto, A. Pesci, F. Luppi, G. Dei, F.I. Romero Bueno, F. Franceschini, I. Chiapparoli, G. Zanframundo, S. Lettieri, L. De Stefano, M. Cutolo, A. Mathieu, M. Piga, S. Prieto-González, M.F. Moraes-Fontes, J.E. Fonseca, V. Jovani, V. Riccieri, A. Santaniello, S. Montfort, D. Bilocca, G.L. Erre, E. Bartoloni, R. Gerli, M.C. Monti, H.M. Lorenz, D. Sambataro, S. Bellando Randone, U. Schneider, C. Valenzuela, R. Lopez-Mejias, J. Cifrian, M. Mejia, M.-I. Gonzalez Perez, S. Wendel, M. Fornaro, G. De Luca, G. Orsolini, M. Rossini, P. Dieude, J. Knitza, S. Castañeda, R.E. Voll, J. Rojas-Serrano, A. Valentini, C. Vancheri, M. Matucci-Cerinic, E. Feist, V. Codullo, F. Iannone, J.H. Distler, C. Montecucco, M.A. Gonzalez-Gay
on behalf of the AENEAS collaborative group
DOI: https://doi.org/10.55563/clinexprheumatol/di1083
CER14849
2022,40,2
Pg. 0284-0291
Free to view
Clinical heterogeneities and prognoses of patients with myositis specific antibody negative dermatomyositis: a retrospective study in China
S. Li, S. Gao, Q. Chen, J. Han, L. Zhang, Y. Ge, Y. Zuo, J. Duan, X. Lu, G. Wang
DOI: https://doi.org/10.55563/clinexprheumatol/t7942l
S. Li, S. Gao, Q. Chen, J. Han, L. Zhang, Y. Ge, Y. Zuo, J. Duan, X. Lu, G. Wang
DOI: https://doi.org/10.55563/clinexprheumatol/t7942l
CER15111
2022,40,2
Pg. 0292-0297
Free to view
Serum Krebs von den Lungen-6 concentrations reflect severity of anti-melanoma differentiation-associated protein 5 antibody positive dermatomyositis associated interstitial lung disease
Y. Zhu, L. Wang, Y. Sun, J. Wang, C. Lv, H. You, L. Xu, F. Wang, M. Zhang, W. Tan, Y. Ke
DOI: https://doi.org/10.55563/clinexprheumatol/zmn18h
Y. Zhu, L. Wang, Y. Sun, J. Wang, C. Lv, H. You, L. Xu, F. Wang, M. Zhang, W. Tan, Y. Ke
DOI: https://doi.org/10.55563/clinexprheumatol/zmn18h
CER15068
2022,40,2
Pg. 0298-0303
Free to view
Anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies: incidence using different testing criteria, and case series
V.M. Joseph, E.C. Rose, C.J. Edwards, M. Lloyd, S.K. Amar, R.D. Wheeler, T. Forster, K.A. Smith, E. Eren, R. Hughes, V. Hajela, P.D. Kiely
DOI: https://doi.org/10.55563/clinexprheumatol/5y19bb
V.M. Joseph, E.C. Rose, C.J. Edwards, M. Lloyd, S.K. Amar, R.D. Wheeler, T. Forster, K.A. Smith, E. Eren, R. Hughes, V. Hajela, P.D. Kiely
DOI: https://doi.org/10.55563/clinexprheumatol/5y19bb
CER15110
2022,40,2
Pg. 0304-0308
Free to view
Anti-melanoma differentiation-associated 5 gene antibody-positive dermatomyositis exhibit three clinical phenotypes with different prognoses
Q. Yang, K. Lyu, J. Li, P. Zhang, W. Guan, L. Zhang, L. Han, S. Liu, T. Li
DOI: https://doi.org/10.55563/clinexprheumatol/df2oc3
Q. Yang, K. Lyu, J. Li, P. Zhang, W. Guan, L. Zhang, L. Han, S. Liu, T. Li
DOI: https://doi.org/10.55563/clinexprheumatol/df2oc3
CER15311
2022,40,2
Pg. 0309-0319
Free to view
Defining anti-synthetase syndrome: a systematic literature review
G. Zanframundo, S. Faghihi-Kashani, C.A. Scirè, F. Bonella, T.J. Corte, T.J. Doyle, D. Fiorentino, M.A. Gonzalez-Gay, M. Hudson, M. Kuwana, I.E. Lundberg, A. Mammen, N. Mchugh, F.W. Miller, C. Monteccucco, C.V. Oddis, J. Rojas-Serrano, J. Schmidt, A. Selva-O'callaghan, V.P. Werth, G. Sakellariou, R. Aggarwal, L. Cavagna
DOI: https://doi.org/10.55563/clinexprheumatol/8xj0b9
G. Zanframundo, S. Faghihi-Kashani, C.A. Scirè, F. Bonella, T.J. Corte, T.J. Doyle, D. Fiorentino, M.A. Gonzalez-Gay, M. Hudson, M. Kuwana, I.E. Lundberg, A. Mammen, N. Mchugh, F.W. Miller, C. Monteccucco, C.V. Oddis, J. Rojas-Serrano, J. Schmidt, A. Selva-O'callaghan, V.P. Werth, G. Sakellariou, R. Aggarwal, L. Cavagna
DOI: https://doi.org/10.55563/clinexprheumatol/8xj0b9
CER15285
2022,40,2
Pg. 0320-0328
Free to view
Treatment and outcomes in anti-HMG-CoA reductase-associated immune-mediated necrotising myopathy. Comparative analysis of a single-centre cohort and published data
J.-G. Rademacher, S. Glaubitz, S. Zechel, M. Oettler, B. Tampe, J. Schmidt, P. Korsten
DOI: https://doi.org/10.55563/clinexprheumatol/2ao5ze
J.-G. Rademacher, S. Glaubitz, S. Zechel, M. Oettler, B. Tampe, J. Schmidt, P. Korsten
DOI: https://doi.org/10.55563/clinexprheumatol/2ao5ze
CER15143
2022,40,2
Pg. 0329-0338
Free to view
Skeletal muscles and Covid-19: a systematic review of rhabdomyolysis and myositis in SARS-CoV-2 infection
J.R. Hannah, S.S. Ali, D. Nagra, M.A. Adas, A.D. Buazon, J.B. Galloway, P.A. Gordon
DOI: https://doi.org/10.55563/clinexprheumatol/mkfmxt
J.R. Hannah, S.S. Ali, D. Nagra, M.A. Adas, A.D. Buazon, J.B. Galloway, P.A. Gordon
DOI: https://doi.org/10.55563/clinexprheumatol/mkfmxt
CER15231
2022,40,2
Pg. 0339-0345
Free to view
Analysis of patient-physician discrepancy in global assessment of systemic autoimmune myopathy disease activity
R.A. Cordeiro, F.M. Fischer, S.K. Shinjo
DOI: https://doi.org/10.55563/clinexprheumatol/keiedv
R.A. Cordeiro, F.M. Fischer, S.K. Shinjo
DOI: https://doi.org/10.55563/clinexprheumatol/keiedv
CER15181
2022,40,2
Pg. 0346-0357
Free to view
MyomiRs in cultured muscle cells from patients with idiopathic inflammatory myopathy are modulated by disease but not by 6-month exercise training
N. Alchus Laiferová, M. Nemec, L. Vernerová, M. Balážová, M. Vokurková, S. Oreská, M. Klein, M. Špiritović, M. Tomčík, J. Vencovský, J. Ukropec, B. Ukropcová
DOI: https://doi.org/10.55563/clinexprheumatol/69z7za
N. Alchus Laiferová, M. Nemec, L. Vernerová, M. Balážová, M. Vokurková, S. Oreská, M. Klein, M. Špiritović, M. Tomčík, J. Vencovský, J. Ukropec, B. Ukropcová
DOI: https://doi.org/10.55563/clinexprheumatol/69z7za
CER14997
2022,40,2
Pg. 0358-0365
Free to view
Range and consistency of outcome measures reported in randomised trials in dermatomyositis: a systematic review
A.H. Kelly, D. Singh-Grewal, D. Sumpton, G. Hasset, K.E. Manera, A. Tong
DOI: https://doi.org/10.55563/clinexprheumatol/3izscd
A.H. Kelly, D. Singh-Grewal, D. Sumpton, G. Hasset, K.E. Manera, A. Tong
DOI: https://doi.org/10.55563/clinexprheumatol/3izscd
CER15303
2022,40,2
Pg. 0366-0372
Free to view
The perils of myositis mimickers with illustrative case reports
I. Marago, J.B. Lilleker, H. Chinoy
DOI: https://doi.org/10.55563/clinexprheumatol/21xrzf
I. Marago, J.B. Lilleker, H. Chinoy
DOI: https://doi.org/10.55563/clinexprheumatol/21xrzf
Reviews
CER14350
2022,40,2
Pg. 0373-0383
Free to view
Myositis-associated interstitial lung disease: a comprehensive approach to diagnosis and management
R.W. Hallowell, J.J. Paik
DOI: https://doi.org/10.55563/clinexprheumatol/brvl1v
R.W. Hallowell, J.J. Paik
DOI: https://doi.org/10.55563/clinexprheumatol/brvl1v
CER15482
2022,40,2
Pg. 0384-0393
Free to view
Diagnostic and prognostic value of anti-cN1A antibodies in inclusion body myositis
S. Salam, M.M. Dimachkie, M.G. Hanna, P.M. Machado
DOI: https://doi.org/10.55563/clinexprheumatol/r625rm
S. Salam, M.M. Dimachkie, M.G. Hanna, P.M. Machado
DOI: https://doi.org/10.55563/clinexprheumatol/r625rm
CER15205
2022,40,2
Pg. 0394-0403
Free to view
Juvenile dermatomyositis. Where are we now?
L.J. Mccann, P. Livermore, M.G. Wilkinson, L.R. Wedderburn
DOI: https://doi.org/10.55563/clinexprheumatol/56ilob
L.J. Mccann, P. Livermore, M.G. Wilkinson, L.R. Wedderburn
DOI: https://doi.org/10.55563/clinexprheumatol/56ilob
CER15508
2022,40,2
Pg. 0404-0413
Free to view
Measuring change in inclusion body myositis: clinical assessments versus imaging
L.N. Alfano, K.L. (focht) Garand, G.A. Malandraki, S. Salam, P.M. Machado, M.M. Dimachkie
DOI: https://doi.org/10.55563/clinexprheumatol/0q2voe
L.N. Alfano, K.L. (focht) Garand, G.A. Malandraki, S. Salam, P.M. Machado, M.M. Dimachkie
DOI: https://doi.org/10.55563/clinexprheumatol/0q2voe
CER15460
2022,40,2
Pg. 0414-0424
Free to view
The role of protein aggregation in the pathogenesis of inclusion body myositis
A.M. Snedden, K.A. Kellett, J.B. Lilleker, N.M. Hooper, H. Chinoy
DOI: https://doi.org/10.55563/clinexprheumatol/pp0oso
A.M. Snedden, K.A. Kellett, J.B. Lilleker, N.M. Hooper, H. Chinoy
DOI: https://doi.org/10.55563/clinexprheumatol/pp0oso
CER15543
2022,40,2
Pg. 0425-0432
Free to view
Fatigue as a common signature of inflammatory myopathies: clinical aspects and care
G. Ricci, L. Fontanelli, F. Torri, E. Schirinzi, G. Siciliano
DOI: https://doi.org/10.55563/clinexprheumatol/p8x98o
G. Ricci, L. Fontanelli, F. Torri, E. Schirinzi, G. Siciliano
DOI: https://doi.org/10.55563/clinexprheumatol/p8x98o
Paediatric Rheumatology
CER13298
2022,40,2
Pg. 0433-0442
Free to view
Myositis-specific autoantibodies and their associated phenotypes in juvenile dermatomyositis: data from a German cohort
S. Horn, K. Minden, F. Speth, T. Schwarz, F. Dressler, N. Grösch, J.-P. Haas, C. Hinze, G. Horneff, A. Hospach, T. Kallinich, J. Klotsche, K. Köstner, C. Meisel, M. Niewerth, P.T. Oommen, C. Schütz, F. Weller-Heinemann, N. Unterwalder, C. Sengler
DOI: https://doi.org/10.55563/clinexprheumatol/94btoy
S. Horn, K. Minden, F. Speth, T. Schwarz, F. Dressler, N. Grösch, J.-P. Haas, C. Hinze, G. Horneff, A. Hospach, T. Kallinich, J. Klotsche, K. Köstner, C. Meisel, M. Niewerth, P.T. Oommen, C. Schütz, F. Weller-Heinemann, N. Unterwalder, C. Sengler
DOI: https://doi.org/10.55563/clinexprheumatol/94btoy
CER14284
2022,40,2
Pg. 0443-0449
Free to view
Identification of 4 subgroups in juvenile dermatomyositis by principal component analysis-based cluster analysis
J. Zhang, Y. Xue, X. Liu, W. Kuang, X. Tan, C. Li, C. Li
DOI: https://doi.org/10.55563/clinexprheumatol/t2hxjd
J. Zhang, Y. Xue, X. Liu, W. Kuang, X. Tan, C. Li, C. Li
DOI: https://doi.org/10.55563/clinexprheumatol/t2hxjd
CER14304
2022,40,2
Pg. 0450-0456
Free to view
A juvenile dermatomyositis: demographics, characteristics and disease outcome in an Egyptian cohort
K. El-Garf, A. El-Garf, S. Salah, H. Marzouk, Y. Farag, N. Mostafa
DOI: https://doi.org/10.55563/clinexprheumatol/h0s7tq
K. El-Garf, A. El-Garf, S. Salah, H. Marzouk, Y. Farag, N. Mostafa
DOI: https://doi.org/10.55563/clinexprheumatol/h0s7tq
CER14030
2022,40,2
Pg. 0457-0470
Free to view
A systematic review on biological therapies in juvenile idiopathic inflammatory myopathies: an evidence gap in precision medicine
E. Marrani, S. Abu-Rumeileh, M.V. Mastrolia, I. Maccora, I. Pagnini, G. Simonini
DOI: https://doi.org/10.55563/clinexprheumatol/ltrj4l
E. Marrani, S. Abu-Rumeileh, M.V. Mastrolia, I. Maccora, I. Pagnini, G. Simonini
DOI: https://doi.org/10.55563/clinexprheumatol/ltrj4l
Letters to the Editor
CER14651
2022,40,2
Pg. 0471-0472
Free to view
Clinical features and pathology of respiratory failure due to inflammatory myopathy induced by immune checkpoint inhibitors
Y. Aratake, K. Obata, K. Nishimura, K. Shindo
DOI: https://doi.org/10.55563/clinexprheumatol/6e9kg9
Y. Aratake, K. Obata, K. Nishimura, K. Shindo
DOI: https://doi.org/10.55563/clinexprheumatol/6e9kg9
CER15263
2022,40,2
Pg. 0473-0474
Free to view
Purtscher-like retinopathy in anti-MDA5 dermatomyositis: a window to underlying microvasculopathy
M. Nohrenberg, Y.F. Tang, S. Varma, X.J. Fagan, A. Hoi
DOI: https://doi.org/10.55563/clinexprheumatol/f6lsk1
M. Nohrenberg, Y.F. Tang, S. Varma, X.J. Fagan, A. Hoi
DOI: https://doi.org/10.55563/clinexprheumatol/f6lsk1